Insider Transactions in Q3 2023 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 21
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.82%
|
$3,160
$8.65 P/Share
|
Jul 21
2023
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-2.12%
|
$3,304
$8.65 P/Share
|
Jul 21
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
255
-0.44%
|
$2,040
$8.65 P/Share
|
Jul 21
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.27%
|
$2,920
$8.65 P/Share
|
Jul 21
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,372
-0.63%
|
$26,976
$8.65 P/Share
|
Jul 21
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.58%
|
$5,336
$8.65 P/Share
|
Jul 20
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.74%
|
$2,872
$8.74 P/Share
|
Jul 20
2023
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-3.06%
|
$4,928
$8.74 P/Share
|
Jul 20
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-0.57%
|
$2,664
$8.74 P/Share
|
Jul 20
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.15%
|
$2,656
$8.74 P/Share
|
Jul 20
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,982
-0.56%
|
$23,856
$8.74 P/Share
|
Jul 20
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.62%
|
$5,736
$8.74 P/Share
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-2.56%
|
$25,272
$8.92 P/Share
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,769
+6.64%
|
-
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,230
-2.0%
|
$9,840
$8.92 P/Share
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,415
+5.26%
|
-
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-2.73%
|
$11,232
$8.92 P/Share
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+7.05%
|
-
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,575
-4.82%
|
$12,600
$8.92 P/Share
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,371
+11.8%
|
-
|
Jul 19
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,379
-2.03%
|
$91,032
$8.92 P/Share
|
Jul 19
2023
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,572
+5.33%
|
-
|
Jul 19
2023
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+24.6%
|
-
|
Jul 19
2023
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+27.4%
|
-
|
Jul 19
2023
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+20.4%
|
-
|
Jul 19
2023
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+20.32%
|
-
|
Jul 19
2023
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+11.68%
|
-
|
Jul 19
2023
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+13.93%
|
-
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
11,384
+19.09%
|
-
|
Jul 19
2023
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+10.85%
|
-
|
Jul 19
2023
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
92,181
+14.69%
|
-
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
10,588
+15.28%
|
-
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,789
+27.13%
|
-
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
28,691
+19.83%
|
-
|
Jul 19
2023
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
14,168
+41.32%
|
-
|
Jul 19
2023
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+50.0%
|
-
|
Jul 17
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-1.69%
|
$2,817
$9.56 P/Share
|
Jul 17
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-0.72%
|
$3,159
$9.56 P/Share
|
Jul 17
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-0.75%
|
$2,511
$9.56 P/Share
|
Jul 17
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,262
-0.51%
|
$20,358
$9.56 P/Share
|
Jul 17
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-0.43%
|
$3,384
$9.56 P/Share
|
Jul 14
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-3.54%
|
$6,111
$9.63 P/Share
|
Jul 14
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-1.06%
|
$4,653
$9.63 P/Share
|
Jul 14
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.58%
|
$5,364
$9.63 P/Share
|
Jul 14
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,906
-1.09%
|
$44,154
$9.63 P/Share
|
Jul 14
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,362
-1.53%
|
$12,258
$9.63 P/Share
|